Acute promyelocytic leukemia with marrow fibrosis at initial presentation: Possible involvement of transforming growth factor-β1

Acta Haematologica

Volumn 103, Issue 4, 2000, Pages 220-223

  Mori, Ako ^a   Wada, Hiroshi ^a   Okada, Masaya ^a   Takatsuka, Hiroyuki ^a   Tamura, Amane ^a   Fujimori, Yoshihiro ^a   Okamoto, Takahiro ^a   Takemoto, Yoshinobu ^a   Kanamaru, Akihisa ^b   Kakishita, Eizo ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

^b KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Acute promyelocytic leukemia; Marrow fibrosis; Transforming growth factor 1

Indexed keywords

ANTINEOPLASTIC AGENT; CYTARABINE; CYTOKINE; DAUNORUBICIN; ENOCITABINE; IDARUBICIN; RETINOIC ACID; TRANSFORMING GROWTH FACTOR BETA1;

ACUTE LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ADULT; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MALE; MYELOFIBROSIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0033803301     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000041054     Document Type: Article

References (16)

1. Kundel DW, Brecher G, Bodey GP, Brittin GM: Reticulin fibrosis and bone infarction in acute leukemia. Implications for prognosis. Blood 1964;23:526-544.
2. Manoharan A, Horsley R, Pitney WR: The reticulin content of hone marrow in acute leukaemia in adults. Br J Haematol 1979;43:185-190.
3. Islam A, Catovsky D, Goldman JM, Galton DAG: Bone marrow fibre content in acute myeloid leukaemia before and after treatment. J ClinPathol 1984;37:1259-1263.
4. Fohlmeister I. Klein H, Thiele J, Wienhold S, Fischer R: Morphometric assessment of hone marrow fiber content in acute nonlymphatic leukemia at presentation. Anal Quant Cytol Histol 1988;10:110-114.
5. Imbert M, Nguyen D, Sultan C: Myelodysplastic syndromes (MDS) and acute myeloid leukemias (AML) with myelofibrosis. Leuk Res 1992;16:51-54.
6. McCarthy DM: Fibrosis of the bone marrow: Content and causes. Br J Haematol 1985;59:1-7.
7. Terui T, Niitsu Y, Mahara K, Fujisaki Y, Urushizaki Y, Mogi Y, Kohgo Y, Watanabe N, Ogura M, Saito H: The production of transforming growth factor-β in acute megakaryoblastic leukemia and its possible implications in myelofibrosis. Blood 1990;75:1540-1548.
8. Kimura A, Nakata Y, Hyodo H, Kuramoto A, Satow Y: Platelet-derived growth factor expression in accelerated and blastic phase of chronic myelogenous leukaemia with myelofibrosis. Br J Haematol 1994;86:303-307.
9. Bousse-Kerdiles MCL, Chevillard S, Charpentier A, Romquin N, Clay D, Smadja-Joffe F, Praloran V, Dupriez B, Demory JL, Jasmin C, Martyre MC: Differential expression of transforming growth factor-β, basic fibroblast growth factor, and their receptors in CD34+ hematopoietic progenitor cells from patients with myelofibrosis and myeloid metaplasia. Blood 1996;88:4534-4546.
10. Kakizuka A, Miller WH Jr, Umesono K, Warrell RP Jr, Frankel SR, Murty VV, Dmitrovsky E, Evans RM: Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML. Cell 1991;66:663-674.
11. Israeli RS, Miller WH Jr, Su SL, Powell CT, Fair WR, Samadi DS, Huryk RF, DeBlasio A, Edwards ET, Wise GJ, Heston WDW: Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells: Comparison of prostate-specific membrane antigen and prostate-specific antigen-based assays. Cancer Res 1994;54:6306-6310.
12. Clare N, Elson D, Manhoff L: Cytogenetic studies of peripheral myeloblasts and bone marrow fibroblasts in acute myelofibrosis. Am J Clin Pathol 1982;77:762-766.
13. Martyre MC: TGF-β and megakaryocytes in the pathogenesis of myelofibrosis in myeloproliferative disorders. Leuk Lymphoma 1995;20: 39-44.
14. Kimura A, Katoh O, Hyodo H, Kuramoto A: Transforming growth factor-β regulates growth as well as collagen and fibronectin synthesis of human marrow fibroblasts. Br J Haematol 1989;72:486-491.
15. Rameshwar P, Chang VT, Gascon P: Implication of CD44 in adhesion-mediated overproduction of TGF-β and IL-I in monocytcs from patients with bone marrow fibrosis. Br J Haematol 1996;93:22-29.
16. Hatzfeld J, Li M, Brown EL, Sookdeo H, Levesque JP, O'Toole T, Gurney C, Clark SC, Hatzfeld A: Release of early human hematopoietic progenitors from quiescence by anti-sense transforming growth factor-β or Rb oligonucleotides. J Exp Med 1991;174:925-929.